BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11005078)

  • 21. Update on viral hepatitis: 2008.
    Degertekin B; Lok AS
    Curr Opin Gastroenterol; 2009 May; 25(3):180-5. PubMed ID: 19387254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Which treatment options are validated for chronic viral hepatitis?].
    Höner zu Siederdissen C; Manns MP; Cornberg M
    Internist (Berl); 2013 Dec; 54(12):1427-8, 1430-3. PubMed ID: 24258199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
    Hunyady B; Gerlei Z; Gervain J; Horváth G; Lengyel G; Pár A; Rókusz L; Szalay F; Telegdy L; Tornai I; Werling K; Makara M
    Orv Hetil; 2015 Mar; 156(9):343-51. PubMed ID: 25702254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis].
    Abdurakhmanov DT
    Ter Arkh; 2013; 85(10):94-7. PubMed ID: 24437226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on viral hepatitis: 2006.
    Tan J; Lok AS
    Curr Opin Gastroenterol; 2007 May; 23(3):263-7. PubMed ID: 17414841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and viral nucleotide sequence analysis of transfusion-transmitted virus infection in acute fulminant and non-fulminant hepatitis.
    Huang YH; Wu JC; Chiang TY; Chan YJ; Huo TI; Huang YS; Hwang SJ; Chang FY; Lee SD
    J Viral Hepat; 2000 Jan; 7(1):56-63. PubMed ID: 10718944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.
    Lau JY; Qian K; Detmer J; Collins ML; Orito E; Kolberg JA; Urdea MS; Mizokami M; Davis GL
    J Infect Dis; 1997 Aug; 176(2):421-6. PubMed ID: 9237707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current issues in the management of paediatric viral hepatitis.
    Yeung LT; Roberts EA
    Liver Int; 2010 Jan; 30(1):5-18. PubMed ID: 19840256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The ABC of viral hepatitis].
    Van Bambeke F
    J Pharm Belg; 2008 Mar; 63(1):15-20. PubMed ID: 18479077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of viral hepatitis].
    Rambusch EG; Manns MP
    Ther Umsch; 1998 Feb; 55(2):71-6, 78-9. PubMed ID: 9545847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma.
    Rasi G; Pierimarchi P; Sinibaldi Vallebona P; Colella F; Garaci E
    Int Immunopharmacol; 2003 Aug; 3(8):1169-76. PubMed ID: 12860172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.
    Gonzalez SA; Keeffe EB
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):225-50. PubMed ID: 21196168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
    Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
    Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral hepatitis in solid organ transplantation other than liver.
    Vallet-Pichard A; Fontaine H; Mallet V; Pol S
    J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.
    Han SH
    Drugs; 2006; 66(14):1831-51. PubMed ID: 17040114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.
    Girndt M
    Drugs Aging; 2008; 25(10):823-40. PubMed ID: 18808207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of recurrent hepatitis B post-liver transplantation.
    Lok AS
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S67-73. PubMed ID: 12362302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure.
    Ayres A; Bartholomeusz A; Lau G; Lam KC; Lee JY; Locarnini S
    J Clin Virol; 2003 May; 27(1):111-6. PubMed ID: 12727536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recommendations of Gesida/PNS/AEEH for the management and treatment of the adult patient co-infected with HIV and hepatitis A, B and C virus].
    Panel de expertos de Gesida, Secretaría del Plan Nacional sobre el Sida (SPNS) y Asociación Española para el Estudio del Hígado (AEEH)
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):31.e1-31. PubMed ID: 20116629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.